Boeing 737 MAX departs for key test flight in China

A Boeing Co (BA.N) 737 Max jet departed for China on Wednesday to conduct a flight test as part of the U.S. planemaker’s attempt to gain approval in the vital travel market following two fatal crashes, people familiar with the matter said.
Siemens raises profit guidance again as industrial demand ramps up

German engineering and technology company Siemens (SIEGn.DE) raised its profit guidance on Thursday for the third time this year on the back of a post-pandemic surge in demand.
Indonesia exits recession with 7% GDP growth in Q2, but virus clouds recovery

Indonesia pulled out of recession in the second quarter, reporting its strongest annual growth rate in 17 years, but analysts warned its economic recovery will suffer a setback due to a recent surge in COVID-19 infections.
Singapore’s DBS bets on post-pandemic recovery, profit up on lower credit costs

Singapore’s DBS Group Holdings (DBSM.SI) flagged strong loan growth and lower credit costs ahead after a rebound in its mainstay home market fuelled a better-than-expected 37% jump in quarterly net profit for Southeast Asia’s biggest lender.
Oil rises on Mideast tensions but virus concerns weigh

Oil prices rose towards $71 a barrel on Thursday on rising Middle East tensions, while fresh movement restrictions imposed by countries to counter a surge in COVID-19 cases threatened the demand recovery.
Wall Street closes mixed, S&P 500 ends off record high

U.S. stocks closed mostly lower on Wednesday, with the S&P 500 falling from a record high after data signaled a slowdown in jobs growth in July, and General Motors tracked its worst day since early March.
New York Auto Show canceled amid Delta variant worries

Organizers on Wednesday canceled the New York Auto Show that had been set for later this month amid rising COVID-19 cases caused by the more infectious Delta variant of the coronavirus amid rethinking of return to offices schedules.
CVS hedges on 2022 earnings growth target as COVID-19 uncertainty persists

CVS Health Corp (CVS.N) on Wednesday hedged a bit on its long-term target for double-digit earnings growth for next year, pointing to uncertainty around COVID-19 vaccination and testing demand, as well as medical costs, sending shares down 3%.
MORNING BID A new sunny day, with the same old clouds

It’s a new week, a new month and time for a fresh start – but the problems niggling at markets this morning are still the same.
France’s Axa rebounds from pandemic as XL unit swings to profit

Axa (AXAF.PA) posted a 180% surge in first-half net income on Monday as the French insurer rebounded from a spike in pandemic-related claims that led to a 1.5 billion euro ($1.8 billion) charge last year.